Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons
- PMID: 8799189
- PMCID: PMC38630
- DOI: 10.1073/pnas.93.17.9264
Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons
Abstract
Voltage-gated Ca2+ channels are categorized as either high-voltage activated (HVA) or low-voltage activated (LVA), and a subtype (or subtypes) of HVA Ca2+ channels link the presynaptic depolarization to rapid neuro-transmitter release. Reductions in transmitter release are characteristic of the autoimmune disorder, Lambert-Eaton syndrome (LES). Because antibodies from LES patients reduce Ca2+ influx in a variety of cell types and disrupt the intramembrane organization of active zones at neuromuscular synapses, specificity of LES antibodies for the Ca2+ channels that control transmitter release has been suggested as the mechanism for disease. We tested sera from four patients with LES. Serum samples from three of the four patients reduced both the maximal LVA and HVA Ca2+ conductances in murine dorsal root ganglion neurons. Thus, even though LES is expressed as a neuromuscular and autonomic disorder, our studies suggest that Ca2+ channels may be broadly affected in LES patients. To account for the specificity of disease expression, we suggest that incapacitation of only a fraction of the Ca2+ channels clustered at active zones would severely depress transmitter release. In particular, if several Ca2+ channels in a cluster are normally required to open simultaneously before transmitter release becomes likely, the loss of a few active zone Ca2+ channels would exponentially reduce the probability of transmitter release. This model may explain why LES is expressed as a neuromuscular disorder and can account for a clinical hallmark of LES, facilitation of neuromuscular transmission produced by vigorous voluntary effort.
Similar articles
-
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.J Bioenerg Biomembr. 2003 Dec;35(6):697-718. doi: 10.1023/b:jobb.0000008033.02320.10. J Bioenerg Biomembr. 2003. PMID: 15000529 Review.
-
Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.J Physiol. 1998 Apr 15;508 ( Pt 2)(Pt 2):427-38. doi: 10.1111/j.1469-7793.1998.427bq.x. J Physiol. 1998. PMID: 9508807 Free PMC article.
-
Heterogeneous calcium currents and transmitter release in cultured mouse spinal cord and dorsal root ganglion neurons.J Neurophysiol. 1992 Mar;67(3):561-75. doi: 10.1152/jn.1992.67.3.561. J Neurophysiol. 1992. PMID: 1374458
-
Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared.J Neurosci. 1996 Aug 15;16(16):4903-13. doi: 10.1523/JNEUROSCI.16-16-04903.1996. J Neurosci. 1996. PMID: 8756422 Free PMC article.
-
Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.Ann N Y Acad Sci. 2018 Jan;1412(1):73-81. doi: 10.1111/nyas.13512. Epub 2017 Nov 10. Ann N Y Acad Sci. 2018. PMID: 29125190 Free PMC article. Review.
Cited by
-
Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.J Physiol. 2002 Sep 1;543(Pt 2):567-76. doi: 10.1113/jphysiol.2002.021048. J Physiol. 2002. PMID: 12205190 Free PMC article.
-
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.J Bioenerg Biomembr. 2003 Dec;35(6):697-718. doi: 10.1023/b:jobb.0000008033.02320.10. J Bioenerg Biomembr. 2003. PMID: 15000529 Review.
-
Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.J Neurosci. 1999 May 1;19(9):3384-95. doi: 10.1523/JNEUROSCI.19-09-03384.1999. J Neurosci. 1999. PMID: 10212298 Free PMC article.
-
Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission.Am J Med Genet A. 2017 Aug;173(8):2240-2245. doi: 10.1002/ajmg.a.38291. Epub 2017 May 25. Am J Med Genet A. 2017. PMID: 28544784 Free PMC article.
-
Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo.Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2705-10. doi: 10.1073/pnas.0710771105. Epub 2008 Feb 13. Proc Natl Acad Sci U S A. 2008. PMID: 18272482 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous